INTEGRA Biosciences and Parse Biosciences offer affordable, automated single cell RNA sequencing

FHS
July 26, 2024
6:16 am

INTEGRA Biosciences and Parse Biosciences have partnered to automate single cell RNA sequencing (scRNA-seq) on the ASSIST PLUS pipetting robot.

Samsung Biologics hits revenue high, secures largest contract to date

Samsung Biologics closed 2024 on several high notes, reaching its highest annual revenue to date — and just a week ago, securing its largest client

January 23, 2025

Filgotinib offers new promise for managing Crohn’s disease

Filgotinib, a JAK1 preferential inhibitor, shows promise as an effective and well-tolerated maintenance therapy for Crohn’s disease, achieving clinical and endoscopic remission in phase 3

December 9, 2024

Acelyrin claims errors by CRO Fortrea led to late-stage trial downfall – Pharmaceutical Technology

Share this article Acelyrin does not plan to utilize this CRO for any new trials evaluating izokibep, after finding that a vendor used by the

November 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.